Sepsis & Septic Shock

A. Master Therapeutic & Escalation Table (Source-Specific Empiric Regimens & Hemodynamics)

B. Crash-Cart Mixing & Drip-Titration Box (Arithmetically Verified)

CRASH-CART PREPARATION, EXTENDED ANTIBIOTIC INFUSIONS & DUAL-PRESSOR RECIPES

1. Prolonged-Infusion Piperacillin-Tazobactam (4.5 g) & Meropenem (2 g) — Maximizing β-Lactam %fT>MIC [BLING III Rationale]:

• Loading Dose (Immediate Bedside Execution — Minute 0): Reconstitute Piperacillin-Tazobactam 4.5 g (or Meropenem 2 g) in 100 mL of 0.9% Normal Saline (45 mg/mL Pip-Tazo; 20 mg/mL Meropenem) and infuse over 30 minutes (200 mL/hr) to rapidly drive serum concentrations above the Minimum Inhibitory Concentration (MIC) [1,10].
• Extended Maintenance Infusions (Starting 4 Hours After Load): Infuse each subsequent 4.5 g Pip-Tazo dose (in 100 mL NS) over 3 to 4 hours (25–33.3 mL/hr) every 6–8 hours [1,10].

2. Weight-Based Vancomycin Loading Dose (25–30 mg/kg) — Preventing Subtherapeutic Levels & Red Man Syndrome:

• Dose Calculation (80 kg Adult): 25 mg/kg × 80 kg = 2,000 mg (Max single loading dose: 3,000 mg).
• Preparation: Reconstitute four 500 mg vials (2,000 mg total) with sterile water and dilute into 500 mL of 0.9% Normal Saline or D5W (Final Concentration = 4 mg/mL; must be ≤ 5 mg/mL for peripheral IV).
• Pump Rate Execution: Infuse at ≤ 10–15 mg/min (2,000 mg over 2 hours = 250 mL/hr) to prevent non-IgE direct mast-cell histamine release (Vancomycin Flushing / Red Man Syndrome).

3. Norepinephrine (16 mcg/mL) + Vasopressin (0.4 Units/mL) Dual Septic Shock Infusions:

• Norepinephrine: 4 mg in 250 mL D5W (16 mcg/mL). For an 80 kg patient:
  • 0.05 mcg/kg/min (4 mcg/min): 15 mL/hr
  • 0.15 mcg/kg/min (12 mcg/min): 45 mL/hr
  • 0.25 mcg/kg/min (20 mcg/min — Threshold to trigger Vasopressin + Hydrocortisone): 75 mL/hr [1].
• Vasopressin: 40 Units in 100 mL NS (0.4 Units/mL) → Fixed Dose 0.03 Units/min (1.8 Units/hr): 1.8 ÷ 0.4 = 4.5 mL/hr (Do not titrate up; wean off after Norepinephrine is reduced below 0.1 mcg/kg/min) [1,6].

4. Stress-Dose Hydrocortisone Continuous Infusion vs. Intermittent Bolus:

• Intermittent Bolus: Reconstitute Hydrocortisone Sodium Succinate 100 mg in 2 mL sterile water; give 50 mg (1 mL) IV push every 6 hours (plus Fludrocortisone 50 mcg PO/NG daily) [1,7].
• Continuous Infusion (Reduces Hyperglycemic Spikes): Add 200 mg of Hydrocortisone into 100 mL of 0.9% Normal Saline (2 mg/mL) and run at 4.2 mL/hr (8.33 mg/hr = 200 mg/24 hr).

C. The Refractory Crashing Patient (Minute 15–30 Salvage & Resource-Limited Bailouts)

When a patient with septic shock remains hypotensive (MAP < 60 mmHg) with rising lactate despite 30 mL/kg balanced crystalloid, Norepinephrine ≥ 0.5 mcg/kg/min, Vasopressin 0.03 U/min, and Hydrocortisone:

1. Hunt & Eliminate Undrained Mechanical Source Control Failures (≤ 2–6 Hours): No vasopressor dose can overcome an undrained collection of pus or necrotic tissue. Perform immediate bedside clinical and POCUS/CT re-evaluation for the “Big 5 Missed Septic Sources”:
   • Necrotizing Fasciitis / Fournier Gangrene (examine the perineum, scrotum, and sacrum in every obtunded septic patient!).
   • Obstructive Pyonephrosis (infected ureteral calculus requiring emergent percutaneous nephrostomy or stent).
   • Acute Ascending Cholangitis (requiring emergent ERCP or percutaneous transhepatic biliary drainage).
   • Acute Mesenteric Ischemia / Perforated Viscus / Empyema.
   • Infected Indwelling Hardware (central venous catheter, port-a-cath, hemodialysis catheter, or retained vaginal tampon/foreign body causing Toxic Shock Syndrome).
2. Identify & Treat Septic Cardiomyopathy (Occurs in 30–40% of Septic Shock): Inflammatory cytokines (TNF-α, IL-1β) and nitric oxide depress myofilament Ca²⁺ sensitivity, causing acute reversible biventricular systolic failure. When Norepinephrine and Vasopressin raise SVR without inotropy, the failing left ventricle cannot eject against the high afterload, and Cardiac Output plummets.
   • Bedside Diagnosis: Repeat POCUS shows LVEF < 35%, LVOT-VTI < 14 cm, ScvO₂ < 65–70%, or ΔPv₋aCO₂ > 6 mmHg.
   • Execution: Add Dobutamine at 2.5–10 mcg/kg/min (or switch/add Epinephrine at 0.05–0.2 mcg/kg/min) to restore LVOT-VTI ≥ 16–18 cm and ScvO₂ ≥ 70% [1].
3. Correct Metabolic Vasopressor Refractory States & Non-Adrenergic Rescue:
   • Ionized Calcium Replacement: Administer Calcium Chloride 10% 1 g (10 mL) IV if iCa²⁺ < 1.0 mmol/L.
   • Severe Acidemia (pH < 7.15) + AKI Stage 2–3 [BICAR-ICU]: Infuse Sodium Bicarbonate (150 mEq in 1 L D5W or 4.2% NaHCO₃) to raise pH > 7.20, reversing α₁-receptor protonation [1].
   • High-Dose Thiamine (Vitamin B1) Metabolic Cofactor Rescue: Administer Thiamine 200–500 mg IV q8h (essential cofactor for Pyruvate Dehydrogenase to convert pyruvate into Acetyl-CoA rather than lactate; Note: Do not administer high-dose IV Vitamin C—forbidden by SSC 2021 and proven harmful in the LOVIT Trial!) [1,11].
   • Methylene Blue (1.5–2 mg/kg IV over 20 min) or Angiotensin II (20–80 ng/kg/min IV) for refractory iNOS/cGMP vasoplegia.

D. Vulnerable Physiological Extremes Matrix (Pregnancy, Pediatrics & Geriatrics)

⚠ E. “NEVER DO THIS & WHY” (Pathophysiological & Mechanical Counter-Examples)

5 LETHAL SEPSIS RESUSCITATION ERRORS & THEIR EXACT MECHANISM OF HARM

1. NEVER administer High-Dose Intravenous Vitamin C (alone or as the “HAT Protocol” with Hydrocortisone and Thiamine) in Sepsis or Septic Shock [SSC 2021 & LOVIT Trial]. Why (Pro-Oxidant Tissue Toxicity, Oxalate Nephropathy & Increased Death/Organ Dysfunction): Multiple randomized controlled trials (VITAMINS, ACTS, VICTAS) showed zero benefit, and the landmark LOVIT Trial (Lamontagne et al., NEJM 2022; N = 872) demonstrated that high-dose IV Vitamin C significantly INCREASED the composite of death or persistent organ dysfunction at Day 28 (44.5% vs. 38.5%; RR 1.21; p = 0.01) [11]. In the presence of free catalytic iron (Fe³⁺) released during sepsis hemolysis, high-dose ascorbate acts as a pro-oxidant via the Fenton reaction (Fe²⁺ + H₂O₂ → Fe³⁺ + OH• + OH⁻), generating hydroxyl radicals, precipitating calcium oxalate crystals in renal tubules, and causing falsely elevated point-of-care glucometer readings that lead to fatal iatrogenic insulin hypoglycemia [1,11]!
2. NEVER use Etomidate for Rapid Sequence Intubation (RSI) in Septic Shock without administering Stress-Dose Hydrocortisone (50–100 mg IV) — or prefer Ketamine instead. Why (Irreversible Inhibition of Adrenal 11β-Hydroxylase): A single induction dose of Etomidate (0.3 mg/kg) binds the heme iron of adrenal mitochondrial cytochrome P450 11β-hydroxylase, blocking the conversion of 11-deoxycortisol to cortisol for 24 to 72 hours. In septic shock—where endogenous cortisol is essential to maintain vascular α₁-receptor transcription—uncompensated adrenal suppression exacerbates refractory vasoplegia. Use Ketamine (0.5–1.0 mg/kg IV) after pre-induction vasopressor stabilization, or co-administer Hydrocortisone 50 mg IV q6h if Etomidate is used.
3. NEVER infuse Vancomycin FIRST before the Broad-Spectrum β-Lactam (Piperacillin-Tazobactam, Cefepime, or Meropenem). Why (Pharmacodynamic Delay in Bactericidal Lysis): Vancomycin requires a 60 to 120 minute slow infusion to avoid Red Man Syndrome and exhibits slow, time-dependent Gram-positive killing. If a nurse hangs Vancomycin first through a single IV line, the life-saving Gram-negative/broad-spectrum β-lactam is delayed by up to 2 hours —increasing mortality by 10–15% in Gram-negative septic shock. Always administer the β-lactam first over 15– 30 minutes (or simultaneously via a second IV line) [1].
4. NEVER reduce the FIRST (Loading) Dose of Hydrophilic Antibiotics (β-Lactams, Vancomycin, Aminoglycosides) for Acute Kidney Injury (CrCl < 30 mL/min) in the Emergency Department. Why (Expanded Volume of Distribution Vd Law): The initial loading dose of any drug depends strictly on the Volume of Distribution (Vd), NOT on renal clearance (Loading Dose = Target Peak Concentration × Vd). In sepsis, capillary leak and 30 mL/kg fluid resuscitation massively expand the extracellular fluid compartment (Vd increases by 50–100%). Giving a “renally reduced” first dose of Cefepime (1 g instead of 2 g) or Vancomycin (1,000 mg instead of 25 mg/kg) guarantees subtherapeutic plasma concentrations (< MIC) during the critical first 12 hours when bacterial burden is highest. Give a 100% full loading dose in the ED, and adjust subsequent maintenance intervals based on renal function [1].
5. NEVER administer Synthetic Starches (Hydroxyethyl Starch [HES]) or Gelatin for Fluid Resuscitation in Sepsis [6S & CHEST Trials]. Why (Osmotic Nephrosis, Coagulopathy & Increased Mortality): Synthetic colloids are pinocytosed into proximal renal tubular epithelial cells, causing osmotic nephrosis and significantly increasing the need for Renal Replacement Therapy and 90-day mortality (6S Trial). If colloid volume expansion is required after large-volume crystalloid resuscitation (> 3–4 L), use 4% or 20% Human Albumin (ALBIOS Trial subgroup benefit in septic shock) [1].

A. Disposition & ICU Escalation Criteria

• Immediate Operating Theater / Interventional Radiology / Endoscopy Suite (Source Control ≤ 2–6 Hours): Necrotizing soft tissue infection (NSTI / Fournier gangrene), perforated viscus, acute mesenteric ischemia, obstructive pyonephrosis (emergent PCN/stent), ascending cholangitis (emergent ERCP), or retained septic products of conception.
  • Note: Resuscitate with antibiotics, balanced fluids, and Norepinephrine simultaneously during transport—never delay the OR waiting for “complete hemodynamic normalization” when the surgical source is driving the shock [1].
• Medical / Surgical Intensive Care Unit (MICU / SICU) Admission: All patients meeting Septic Shock criteria (vasopressor requirement or persistent Lactate > 4.0 mmol/L), patients requiring mechanical ventilation or non-invasive respiratory support (HFNC/BiPAP), or patients with acute multi-organ dysfunction (ΔSOFA ≥ 2 with oliguric AKI, coagulopathy, or encephalopathy).
• High-Dependency Unit (HDU) / Inpatient Telemetry Ward Admission: Patients with Sepsis without Shock whose MAP remains ≥ 65 mmHg off vasopressors after fluid resuscitation, with CRT ≤ 3.0 s, downward-trending lactate (< 2.0 mmol/L), and stable oxygenation.

B. Program Director’s Quality KPIs, Accreditation (JCI / CBAHI / GAHAR / Ada’a) & M&M Audit Points

• Door-to-Sepsis Screening Time: ≤ 15 minutes at ED Triage using an automated EHR early warning trigger (NEWS2 ≥ 5 or SIRS ≥ 2 + infection).
• Door-to-Antibiotic Administration Time (The #1 Saudi MoH Ada’a / JCI / CMS SEP-1 Metric):
  • Septic Shock or High-Likelihood Sepsis: ≤ 60 minutes from triage/recognition (Target median < 45 min) [1].
  • Mandatory Sequencing Audit: 100% compliance with hanging the broad-spectrum β-lactam FIRST (or simultaneously via a second line) prior to Vancomycin.
• Blood Culture Quality KPI: ≥ 90% of septic shock patients have 2 sets of blood cultures drawn prior to first antibiotic dose (with zero delay > 45 min) and a contamination rate < 3% [1].
• Lactate Turnaround & Repeat Mandate: Initial point-of-care lactate resulted within ≤ 30 minutes; mandatory repeat lactate drawn within ≤ 3 hours for any initial lactate > 2.0 mmol/L.
• M&M Audit & Medicolegal Documentation Mandate (Fluid Exception Charting): When a patient has Sepsis-Induced Hypotension or Lactate ≥ 4.0 mmol/L, CMS SEP-1 and CBAHI auditors track 30 mL/kg crystalloid completion within 3 hours. If the clinician appropriately restricts fluids to < 30 mL/kg due to decompensated HFrEF, ESRD, or Lung POCUS B-lines, the physician MUST explicitly document the contraindication and POCUS findings in the chart alongside early Norepinephrine initiation.

C. Structured Clinical SBAR Handover (ED Consultant to ICU & Urology / IR Consultants)

A. OSCE & Oral Board Examiner Rubric (Topic 1.3)

To achieve a Pass / Distinction rating on a Sepsis & Septic Shock Resuscitation OSCE Station, the candidate must execute and verbalize the following 4 critical milestones:

1. Accurate Sepsis-3 & Hour-1 Bundle Execution: Identifies Sepsis (ΔSOFA ≥ 2) and Septic Shock (MAP < 65 on pressors + Lactate > 2.0 mmol/L) [2], draws two sets of blood cultures (40 mL total) without delaying therapy, and orders point-of-care lactate [1].
2. Pharmacokinetically Optimized Antimicrobial Delivery (≤ 1 Hour): Selects source-appropriate broad-spectrum coverage, explicitly orders full unadjusted loading doses (despite any AKI), sequences the β-lactam to infuse FIRST before Vancomycin, and verbalizes prolonged/extended β-lactam infusions for maintenance dosing [1,10].
3. Balanced Crystalloid + Early Peripheral Norepinephrine Strategy: Orders Lactated Ringer’s or Plasma-Lyte (30 mL/kg guided by dynamic POCUS LVOT-VTI/PLR and lung B-lines) [1,3], initiates Norepinephrine via a proximal peripheral IV without waiting for central line placement [4,5], and escalates to Vasopressin (0.03 U/min) + Hydrocortisone (50 mg IV q6h) at Norepinephrine ≥ 0.25 mcg/kg/min [1,6,7].
4. Capillary Refill Time (CRT) Endpoint & Urgent Source Control (< 6 Hours): Titrates resuscitation to MAP ≥ 65 mmHg and standardized CRT ≤ 3.0 seconds (ANDROMEDA-SHOCK) [8], and immediately mobilizes surgical/IR consultation for mechanical source control when an abscess, obstruction, or necrotizing infection is identified [1].

B. 2 Board-Style Clinical Vignette MCQs (SCFHS / MRCEM / ABEM Level)

Vignette 1: A 61-year-old female with a history of type 2 diabetes mellitus presents to the Emergency Department with 18 hours of severe pain and swelling in her left lower extremity following a minor skin abrasion 3 days ago. Her vital signs are: BP 72/38 mmHg (MAP 49 mmHg), HR 136 bpm, RR 30/min, temperature 38.9°C, and SpO₂ 95% on room air. Examination of the left calf reveals tense edema extending to the knee, hemorrhagic bullae, cutaneous anesthesia over the central violaceous plaque, and severe pain upon passive ankle dorsiflexion. Point-of-care arterial blood gas and labs show pH 7.18, Lactate 6.8 mmol/L, WBC 28,400/µL, Na⁺ 128 mEq/L, and Creatinine 2.6 mg/dL (baseline 0.9 mg/dL). Two sets of blood cultures are drawn, 2,000 mL of Lactated Ringer’s is infused, and a peripheral Norepinephrine infusion is initiated at 0.15 mcg/kg/min. In addition to immediate surgical consultation for operative fasciotomy and radical debridement, which of the following is the most appropriate initial intravenous antimicrobial regimen?

• A. Renally dose-adjusted Piperacillin-Tazobactam 2.25 g IV q8h plus Daptomycin 6 mg/kg IV q48h after obtaining a contrast-enhanced MRI of the left leg.
• B. Full loading doses of Meropenem 2 g IV, Vancomycin 25–30 mg/kg IV, and Clindamycin 900 mg IV administered immediately without waiting for advanced imaging.
• C. Ceftriaxone 2 g IV plus Metronidazole 500 mg IV, plus High-Dose Intravenous Vitamin C (50 mg/kg IV q6h).
• D. Vancomycin 1,000 mg IV infused over 90 minutes first, followed by Cefazolin 2 g IV once the Vancomycin infusion is complete.

Correct Answer: B.

Mechanism & Explanation: This patient has Type I/II Necrotizing Soft Tissue Infection (Necrotizing Fasciitis) complicated by Septic Shock and Toxic Shock Syndrome (evidenced by pain out of proportion, hemorrhagic bullae, cutaneous anesthesia from thrombosis of perforating subcutaneous nerves, hyponatremia, and hyperlactatemia). Definitive survival requires immediate surgical debridement in the OR (never delayed for CT/MRI) plus broad-spectrum polymicrobial and anti-toxin therapy: Meropenem 2 g IV (or Piperacillin-Tazobactam 4.5 g IV) for Gram-negatives and anaerobes, Vancomycin 25–30 mg/kg IV for MRSA, and Clindamycin 900 mg IV q8h (or Linezolid) [1]. Clindamycin is mandatory because in high-inoculum stationary-phase Streptococcus pyogenes or Clostridium perfringens infections, Penicillin-Binding Proteins are not expressed (the Eagle Effect), rendering β-lactams ineffective; Clindamycin binds the 50S ribosome to halt synthesis of lethal superantigens (SpeA/SpeB) and α-toxin. Full loading doses must be given despite the Creatinine of 2.6 mg/dL due to the expanded Volume of Distribution (Vd) in sepsis [1].

Why Distractors Fail: A delays the OR for an MRI and dangerously underdoses the initial β-lactam loading dose in AKI. C lacks MRSA and anti-ribosomal toxin coverage and includes High-Dose IV Vitamin C, which increased mortality/organ dysfunction in the LOVIT Trial [11]. D sequences Vancomycin before the β-lactam, underdoses Vancomycin, and uses narrow-spectrum Cefazolin.

Vignette 2: A 74-year-old male with severe community-acquired pneumonia and septic shock is being resuscitated in the Emergency Department. Over the first 2 hours, he has received Ceftriaxone 2 g IV, Azithromycin 500 mg IV, and 2,200 mL (30 mL/kg) of Plasma-Lyte. He is intubated and mechanically ventilated on lung-protective settings. A right internal jugular central venous catheter and radial arterial line are in place. He is currently receiving Norepinephrine at 0.28 mcg/kg/min and Vasopressin at 0.03 Units/min, maintaining a MAP of 67 mmHg. His initial arterial lactate was 5.8 mmol/L, and his 2-hour repeat lactate is 4.9 mmol/L. Standardized index-finger Capillary Refill Time (CRT) has normalized from 5.5 seconds on arrival to 2.0 seconds. Bedside POCUS reveals a left ventricular ejection fraction of 60%, an LVOT-VTI of 20 cm, a Passive Leg Raise (PLR) ΔLVOT-VTI of +3% (fluid non-responsive), and bilateral pulmonary B-lines. Central venous oxygen saturation (ScvO₂) is 74%, and the veno-arterial CO₂ gap (ΔPv₋aCO₂) is 4 mmHg. According to the 2021 Surviving Sepsis Campaign guidelines, the ANDROMEDA-SHOCK trial, and the CAPE COD / APROCCHSS trials, what is the most appropriate next step in his management?

• A. Administer an additional 2,000 mL bolus of 0.9% Normal Saline and start Dobutamine at 10 mcg/kg/min because his serum lactate remains > 4.0 mmol/L.
• B. Administer Stress-Dose Hydrocortisone (50 mg IV every 6 hours or 200 mg/day continuous infusion) and maintain current vasopressor and fluid rates without giving further fluid boluses.
• C. Increase Vasopressin to 0.08 Units/min and switch Norepinephrine to Dopamine at 20 mcg/kg/min to improve renal perfusion.
• D. Administer Epoprostenol and Sodium Bicarbonate 100 mEq IV push to rapidly normalize the serum lactate.

Correct Answer: B.

Mechanism & Explanation: This patient has achieved microcirculatory and macrocirculatory resuscitation (MAP 67 mmHg, normalized CRT of 2.0 seconds, normal stroke volume [LVOT-VTI 20 cm], normal ScvO₂ [74%], and normal ΔPv₋aCO₂ [4 mmHg]), and his lactate is actively clearing (5.8 → 4.9 mmol/L). Per the ANDROMEDA-SHOCK trial, once CRT is normalized (≤ 3.0 s) and the patient is fluid non-responsive (PLR ΔVTI < 10–15%) with pulmonary B-lines, administering additional fluids or inotropes to chase residual serum lactate causes harm [8]. Because he has severe ICU community-acquired pneumonia (CAPE COD trial: 5.6% absolute mortality reduction with Hydrocortisone 200 mg/day) and refractory septic shock requiring Norepinephrine ≥ 0.25 mcg/kg/min (APROCCHSS trial & SSC 2021), initiating Stress-Dose Hydrocortisone (50 mg IV q6h / 200 mg/day) is strongly indicated to accelerate shock reversal and reduce mortality [1,7,9].

Why Distractors Fail: A causes iatrogenic pulmonary edema in a fluid-non-responsive patient with B-lines and adds unnecessary Dobutamine to an already normal heart (LVEF 60%). C uses toxic doses of Vasopressin (> 0.04 U/min causes mesenteric/digital necrosis) and switches to arrhythmogenic Dopamine (SOAP II). D is incorrect because empiric bicarbonate does not treat hyperlactatemia when pH ≥ 7.15.